QuartataWeb
Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

 

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: O00555
No. Gene UniProt ID Protein Name Pathway PDB
1 CACNA1A O00555 Voltage-dependent P/Q-type calcium channel subunit alpha-1A hsa04010; hsa04020; hsa04721; hsa04723; hsa04724; hsa04725; hsa04726; hsa04727; hsa04728; hsa04730; hsa04742; hsa04930; hsa05032; hsa05033 3BXK


8 known interactions (drugs) of input target (CACNA1A): Voltage-dependent P/Q-type calcium channel subunit alpha-1A
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image
1 Approved SmallMoleculeDrug DB00421 Spironolactone Thumb
2 Approved SmallMoleculeDrug DB00836 Loperamide Thumb
3 Approved;
Withdrawn
SmallMoleculeDrug DB11148 Butamben Thumb
4 Approved;
Withdrawn
SmallMoleculeDrug DB01244 Bepridil Thumb
5 Approved;
Illicit;
Investigational
SmallMoleculeDrug DB00230 Pregabalin Thumb
6 Investigational SmallMoleculeDrug DB06446 Dotarizine Thumb
7 Approved;
Experimental
SmallMoleculeDrug DB13746 Bioallethrin Thumb
8 Approved SmallMoleculeDrug DB00661 Verapamil Thumb


20 predicted interactions (drugs) of input target (CACNA1A): Voltage-dependent P/Q-type calcium channel subunit alpha-1A
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Approved;
Investigational
SmallMoleculeDrug DB01023 Felodipine Thumb 60.0%
2 Approved SmallMoleculeDrug DB00381 Amlodipine Thumb 57.7%
3 Approved;
Investigational
SmallMoleculeDrug DB00568 Cinnarizine Thumb 55.7%
4 Approved;
Investigational
SmallMoleculeDrug DB09229 Aranidipine Thumb 54.6%
5 Approved;
Investigational
SmallMoleculeDrug DB00622 Nicardipine Thumb 53.8%
6 Approved SmallMoleculeDrug DB04855 Dronedarone Thumb 53.7%
7 Approved;
Investigational
SmallMoleculeDrug DB09231 Benidipine Thumb 52.6%
8 Approved;
Investigational
SmallMoleculeDrug DB09238 Manidipine Thumb 50.2%
9 Approved;
Investigational
SmallMoleculeDrug DB09061 Cannabidiol Thumb 49.8%
10 Approved SmallMoleculeDrug DB00898 Ethanol Thumb 49.0%
11 Investigational;
Withdrawn
SmallMoleculeDrug DB01388 Mibefradil Thumb 48.9%
12 Approved SmallMoleculeDrug DB09089 Trimebutine Thumb 48.9%
13 Experimental;
Investigational
BiotechDrug DB14009 Medical Cannabis Thumb 48.6%
14 Approved SmallMoleculeDrug DB00825 Menthol Thumb 47.7%
15 Approved;
Investigational
SmallMoleculeDrug DB14011 Nabiximols Thumb 47.2%
16 Approved;
Investigational
SmallMoleculeDrug DB01054 Nitrendipine Thumb 47.2%
17 Approved SmallMoleculeDrug DB01115 Nifedipine Thumb 46.8%
18 Approved SmallMoleculeDrug DB04841 Flunarizine Thumb 46.1%
19 Approved;
Investigational
SmallMoleculeDrug DB00270 Isradipine Thumb 44.3%
20 Approved;
Investigational
SmallMoleculeDrug DB09232 Cilnidipine Thumb 43.1%



  logl

Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.

Contact:

The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.